Insider Transactions Reported by 18 Insiders of Anika Therapeutics, Inc.

Symbol
ANIK on Nasdaq
Location
Bedford, MA

There are no Buy or Sell transactions made by insiders since 12/15/2024

Anika Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Cheryl R. Blanchard President, CEO, Director, Director $6.07M Mar 14, 2025
Michael L. Levitz EVP, CFO, Treasurer $1.76M Mar 15, 2024
David Colleran EVP, General Counsel, Corp Sec $1.47M Mar 14, 2025
Stephen D. Griffin Evp, Cfo & Coo $1.4M Jun 3, 2025
Anne Nunes SVP, Chief Operations Officer $726K Mar 14, 2025
Thomas Finnerty EVP, Human Resources $590K Mar 9, 2022
Jeffery S. Thompson Director $588K Jun 14, 2023
Glenn R. Larsen Director $565K Jun 20, 2025
Susan Vogt Director $564K Jun 20, 2025
John B. Henneman III Director $561K Jun 20, 2025
Stephen Richard Director $538K Jun 20, 2025
Sheryl L. Conley Director $478K Jun 20, 2025
Gary P. Fischetti Director $468K Jun 20, 2025
William R. Jellison Director $260K Jun 20, 2025
Ian McLeod VP, CAO and Treasurer $255K Apr 5, 2025
Joseph H. Capper Director $229K Jun 20, 2025
Raymond J. Land Director $226K Jun 16, 2021
James Loerop EVP Business Development $182K Jul 8, 2021

Recent Insider Transactions by Companies or Individuals for Anika Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.